English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Due to a growing interest in the occurrence of pharmaceutically active compounds (PhACs) and endocrine disrupting compounds (EDCs) in the aquatic environment and their potential impacts on humans and the environment, a collaborative study was conducted on these emerging contaminants in the effluents from the wastewater treatment plants (WWTPs) and in the drinking water supply system of Calgary, Alberta. A number of PhACs and EDCs were detected in the WWTP effluents, at concentrations ranging from ng/L to low µg/L. Although these compounds were generally removed from WWTP effluents during wastewater treatment, some compounds, such as carbamazepine were more persistent. Some target PhACs and EDCs were detected at low ng/L levels in the surface and potable water in this study. Currently, there is no evidence that trace amounts of PhACs and EDCs in Calgary’s waterways can have a health impact on humans, but they may pose adverse chronic effects on aquatic life.

Pharmaceuticals and Endocrine Disruptors in Wastewater Treatment Effluents and in the Water Supply System of Calgary, Alberta, Canada